Back to Search Start Over

Activated Peritoneal Cavity B-1a Cells Posses Regulatory B Cell Properties

Authors :
Margry, B.
Kersemakers, S.C.W.
Hoek, A.
Arkesteijn, G.J.A.
Wieland, W.H.
van Eden, W.
Broere, F.
Risk Assessment of Toxic and Immunomodulatory Agents
Strategic Infection Biology
I&I RATIA-SIB
Dep Infectieziekten Immunologie
Publication Year :
2014

Abstract

Previous studies have suggested that murine peritoneal cavity-derived B-1a cells possess similarities with described regulatory B cell subsets. The aim of the current study was to examine the potential immunoregulatory function of peritoneal cavity-derived B(-1a) cells. In vitro activation of peritoneal cavity-derived B- and B-1a cells shows that activation of these B cells with anti-CD40 and LPS induces these cells to secrete more IL-10, IL-6 and IgM as compared to splenic B cells. In a suppression assay, CD40/TLR4-activated peritoneal cavity B cells possess regulatory B cell functions as they inhibit the capacity of CD4+ T cells to produce both tumor necrosis factor-α and interferon-γ. Splenic B cells did not show this, whereas non-activated peritoneal cavity B cells augmented the capacity of CD4+ T cells to produce tumor necrosis factor-α, while the ability to produce interferon-γ was not altered. The current paper compares splenic B cells to peritoneal cavity B(-1a) cells in an in vitro activation- and an suppression-assay and concludes that peritoneal cavity B(-1a) cells possess properties that appear similar to splenic autoimmune-suppressive regulatory B cell subsets described in the literature.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od.......101..a1b9f46d70892a385047bc67530bb7ae